The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus
- 1 April 2008
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (7), 3555-3560
- https://doi.org/10.1128/jvi.01977-07
Abstract
Hepatitis C virus (HCV) is a major cause of liver disease in humans. The CD81 tetraspanin is necessary but not sufficient for HCV penetration into hepatocytes, and it was recently reported that the tight junction protein claudin-1 is a critical HCV entry cofactor. Here, we confirm the role of claudin-1 in HCV entry. In addition, we show that claudin-6 and claudin-9 expressed in CD81(+) cells also enable the entry of HCV pseudoparticles derived from six of the major genotypes. Whereas claudin-1, -6, and -9 function equally well as entry cofactors in endothelial cells, claudin-1 is more efficient in hepatoma cells. This suggests that additional cellular factors modulate the ability of claudins to function as HCV entry cofactors. Our work has generated novel and essential means to investigate the mechanism of HCV penetration into hepatocytes and the role of the claudin protein family in HCV dissemination, replication, and pathogenesis.Keywords
This publication has 29 references indexed in Scilit:
- Claudin-6 and Claudin-9 Function as Additional Coreceptors for Hepatitis C VirusJournal of Virology, 2007
- Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic reviewBritish Journal of Cancer, 2007
- The effects of HCV infection and management on health-related quality of lifeHepatology, 2007
- Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryNature, 2007
- Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated VesiclesJournal of Virology, 2006
- In Vitro Interaction between Hepatitis C Virus (HCV) Envelope Glycoprotein E2 and Serum Lipoproteins (LPs) Results in Enhanced Cellular Binding of Both HCV E2 and LPsThe Journal of Infectious Diseases, 2006
- High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entryJournal of General Virology, 2006
- Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter VirusesJournal of Virology, 2006
- Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle EntryJournal of Virology, 2006
- Regulation of the blood?biliary barrier: interaction between gap and tight junctions in hepatocytesMedical Molecular Morphology, 2003